XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$154.75
+0.32 (+0.21%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$155.58
Prev Close$154.43
Day Range$152.56 — $155.90
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
17.2%
From 52W Low
+132.1%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $154.75 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,904.00
Annual Income$9.90
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $262.82 | +1.11% | 459.33B |
| AMGN | $401.74 | -0.32% | 219.33B |
| GILD | $144.74 | -1.87% | 179.15B |
| VRTX | $505.01 | +0.06% | 132.51B |
| MRNA | $201.09 | +5.83% | 75.82B |
| REGN | $722.64 | -1.71% | 75.36B |
| NTRA | $416.44 | +1.48% | 58.12B |
| RVMD | $206.70 | +0.03% | 44.29B |
| BIIB | $219.68 | -0.09% | 32.75B |
| ALNY | $218.55 | -0.53% | 29.82B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Oct 5, 2026 at 4:17 PM ET